These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 311566
1. [Diagnosis of T-immunodeficiencies in lupus erythematosus and patient treatment with levamisole]. Shaposhnikov OK, Gorbunov VF. Vestn Dermatol Venerol; 1979 Mar; (3):3-6. PubMed ID: 311566 [No Abstract] [Full Text] [Related]
3. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population. Pozsonyi T, Jakab L, Fehér J. Allergol Immunopathol (Madr); 1980 Jul; 8(5):553-8. PubMed ID: 6970515 [Abstract] [Full Text] [Related]
4. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus]. Gandzha IM, Sakharchuk VM, Lysenko GI. Ter Arkh; 1981 Jul; 53(7):121-4. PubMed ID: 6457406 [No Abstract] [Full Text] [Related]
6. [Study of T lymphocyte subpopulations in patients with lupus erythematosus using monoclonal antibodies during immunocorrective therapy]. Berenbeĭn BA, Kagramanov GV, Slavina EG. Vestn Dermatol Venerol; 1987 May; (3):10-3. PubMed ID: 3300088 [No Abstract] [Full Text] [Related]
7. Treatment of systemic lupus erythematosus with the T-cell immunopotentiator levamisole: a follow-up report of 16 patients under treatment for a minimum period of four months. Gordon BL, Yanagihara R. Ann Allergy; 1977 Oct; 39(4):227-36. PubMed ID: 71868 [Abstract] [Full Text] [Related]
8. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Wouters CH, Diegenant C, Ceuppens JL, Degreef H, Stevens EA. Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365 [Abstract] [Full Text] [Related]
9. [Immunologic deficiency states in adults]. Gandzha IM. Vrach Delo; 1981 Apr; (4):98-100. PubMed ID: 6973888 [No Abstract] [Full Text] [Related]
10. Chronic disseminated discoid lupus erythematosus with linear lesions following Blaschko's lines on forearm and hand. Verma SB, Wollina U. J Dtsch Dermatol Ges; 2012 Feb; 10(2):129-30. PubMed ID: 21951726 [No Abstract] [Full Text] [Related]
11. The treatment of systemic lupus erythematosus (SLE) with the T-cell immunostimulant drug levamisole: A case report. Gordon BL, Keenan JP. Ann Allergy; 1975 Dec; 35(6):343-55. PubMed ID: 1081857 [Abstract] [Full Text] [Related]
13. [Discoid lupus erythematosus as a sign of systemic lupus erythematosus]. Bardelli A, Parodi A, Rebora A. G Ital Dermatol Venereol; 1983 Apr; 118(4):195-8. PubMed ID: 6671688 [No Abstract] [Full Text] [Related]
14. Immunodeficiency diseases with rheumatic manifestations. Torgerson TR. Pediatr Clin North Am; 2012 Apr; 59(2):493-507. PubMed ID: 22560581 [Abstract] [Full Text] [Related]
16. [Clinical and electroencephalographic studies in lupus erythematosus]. Levin MI, Angelova VS. Vestn Dermatol Venerol; 1966 Sep; 40(9):35-41. PubMed ID: 5998173 [No Abstract] [Full Text] [Related]
17. [Chronic discoid lupus erythematosus as a disease in internal medicine, with special reference to the cases with difficulty in differentiation from SLE]. Okuda M, Nishido T, Okamoto S. Naika; 1971 Apr; 27(4):752-60. PubMed ID: 4101751 [No Abstract] [Full Text] [Related]
18. Levamisole in the treatment of systemic lupus erythematosus--preliminary results. Feng PH, Oon CJ, Yo SL, Lau YK. Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195 [No Abstract] [Full Text] [Related]
19. [Levamisole in the combined treatment of patients with ischemic heart disease]. Gorb GD, Makovskaia TE, Tsybul'nik ZI, Grushko IV, Eremeev VS. Vrach Delo; 1988 Aug; (8):38-40. PubMed ID: 3264642 [No Abstract] [Full Text] [Related]
20. [Relation between the discoid and systemic lupus erythematosus]. Nesgovorova LI, Nasonova VA, Speranskiĭ AI. Ter Arkh; 1973 Jan; 45(1):27-34. PubMed ID: 4770017 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]